Business ❯ Pharmaceuticals

Licensing Agreements

Product Development Cancer Treatment Sanofi Obesity Medications Collaborations Drug Development Market Strategy Cancer Drugs Arrowhead Pharmaceuticals Partnerships Oncology Patent Litigation

Bristol Myers and Hengrui Ink Up to $15.2 Billion Drug Discovery Alliance

The pact reflects big pharma’s push to tap Chinese discovery engines.

Stories older than 24h

Lilly Licenses MeiraGTx Eye Gene Therapy in Deal Worth Up to $475 Million

Novartis Licenses Arrowhead’s RNAi Parkinson’s Drug in Deal Worth Up to $2.2 Billion